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Abstract
Background: We previously demonstrated that a computerized psychiatric screening interview (the
PRIME-MD) can be used in the Emergency Department (ED) waiting room to identify patients with mental
illness. In that trial, however, informing the ED physician of the PRIME-MD results did not increase the
frequency of psychiatric diagnosis, consultation or referral. We conducted this study to determine
whether telling the patient and physician the PRIME-MD result would result in the majority of PRIME-MD-
diagnosed patients being directed toward treatment for their mental illness.
Methods: In this single-site RCT, consenting patients with non-specific somatic chief complaints (e.g.,
fatigue, back pain, etc.) completed the computerized PRIME-MD in the waiting room and were randomly
assigned to one of three groups: patient and physician told PRIME-MD results, patient told PRIME-MD
results, and neither told PRIME-MD results.
The main outcome measure was the percentage of patients with a PRIME-MD diagnosis who received a
psychiatric consultation or referral from the ED.
Results: 183 (5% of all ED patients) were approached. 123 eligible patients consented to participate,
completed the PRIME-MD and were randomized. 95 patients had outcomes recorded. 51 (54%) had a
PRIME-MD diagnosis and 8 (16%) of them were given a psychiatric consultation or referral in the ED.
While the frequency of consultation or referral increased as the intervention's intensity increased (tell
neither = 11% (1/9), tell patient 15% (3/20), tell patient and physician 18% (4/22)), no group came close to
the 50% threshold we sought. For this reason, we stopped the trial after an interim analysis.
Conclusion: Patients willingly completed the PRIME-MD and 54% had a PRIME-MD diagnosis.
Unfortunately, at our institution, informing the patient (and physician) of the PRIME-MD results
infrequently led to the patient being directed toward care for their psychiatric condition.
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There is a higher prevalence of psychiatric conditions in
patients presenting to emergency departments (ED)s with
non-emergent complaints than in the general population
[1-4]. On average, patients with untreated psychiatric ill-
ness have more frequent ED visits and use more health
care services than those in the general public [5,6]. Studies
in a variety of ED settings have documented that over 40%
of ambulatory patients have underlying psychiatric condi-
tions [1-4]. Since there are highly effective treatments for
many psychiatric conditions, these patients are generally
expected to achieve better health outcomes if their psychi-
atric condition is diagnosed and treated, especially when
their somatic complaints (weak and dizzy, back pain, etc.)
are not amenable to effective treatment. A collateral bene-
fit would be a reduction in societal health care costs [7].
PRIME-MD is a screening tool for psychiatric conditions
that uses closed ended questions to make DSM-IV diag-
noses [8]. Its diagnostic validity has been established in a
number of ambulatory care settings [9-12]. We have dem-
onstrated that the computer version of the PRIME-MD can
be used in the ED waiting room to identify patients with
underlying psychiatric conditions that might be causing
or exacerbating their somatic presenting complaints [4].
Unfortunately, in that study, the emergency physicians
ignored the patient's PRIME-MD diagnoses and neither
diagnosed nor treated the patient's mental health disor-
der. The same phenomenon has been observed in primary
care [13].
In this study, we conducted focus groups to determine
why our first trial failed and then conducted a trial using
the stronger intervention of informing both the patient
and the physician of the computer's findings. Our goal
was to determine whether this intervention would result
in the majority of patients with a PRIME-MD diagnosis
being referred for evaluation and treatment of their psy-
chiatric condition. By empowering the patient to act as his
or her own advocate, we hoped to overcome whatever fac-
tors deter physicians from exploring these diagnostic pos-
sibilities with the patient. We designed a 3-limb
randomized trial that included a control group, a group in
which only the patient was informed of the PRIME-MD
results and a group in which both patient and physician
were informed of the results.
Methods
Study design and setting
Focus groups – An experienced facilitator used a set of
open ended probes to conduct two 90 minute focus
groups to explore why physicians might be reluctant to
pursue psychiatric diagnosis, consultation or referral in
patients given a psychiatric diagnosis by PRIME-MD. One
group included 6 randomly selected EM residents, the
other 6 EM faculty. Two observers took notes and identi-
fied main themes and points of disagreement. The results
informed the development of the intervention and study
materials.
Trial – This randomized, controlled clinical trial was con-
ducted at the University of California Los Angeles Emer-
gency Department, a teaching hospital and Level I trauma
center. The annual census is 44,000. Study subjects
included emergency and internal medicine house staff,
emergency medicine faculty, and enrolled patients, all of
whom were consented. The study was approved by the
UCLA IRB.
Selection of participants
Patients age 18 or older presenting to the ED between the
hours of 10 a.m. and 9 p.m. on most (84%) weekdays
from March to September 2002 were recruited for study
participation. A trained research assistant, stationed at the
triage desk, listened to each intake interview and identi-
fied adults with diffuse somatic complaints (e.g., vague
head, abdominal, back or body pain of non-acute onset;
generalized weakness; "don't feel well") that did not seem
to mandate emergency care or did not coincide with phys-
ical findings (e.g. complaining of rash but no rash visi-
ble). Patients arriving via ambulance, patients in extremis,
and patients who indicated they were not comfortable
reading English were excluded; as were patients whose
symptoms suggested psychiatric illness (e.g. hearing
voices, suicidal ideation, anxiety...), patients with recent
substance abuse, and patients who already participated in
the trial.
Intervention
Consenting patients were asked to complete the self-
administered, PRIME-MD computerized psychiatric ques-
tionnaire (version 1.2, Pfizer, Inc, New York, NY) in the
ED waiting room prior to seeing the physician. PRIME-
MD poses a series of questions to screen patients in 7 psy-
chiatric domains (mood, anxiety, alcohol abuse, eating
disorder, obsessive-compulsive disorder, phobia, and
somatization). Positive responses to these screening ques-
tions trigger additional questions to confirm or reject par-
ticular diagnoses within each domain. When the session is
complete, the program prints a grid that indicates the
presence or absence of 20 specific diagnoses within the 7
domains.
Patients were seated at a computer secluded from the rest
of the waiting room. They answered questions using a
Fastpoint light pen (Fastpoint Technologies, Stanton,
CA). A research associate was present to assist with techni-
cal issues, time the session, and record any difficulties
with the hardware or software. Upon conclusion of the
PRIME-MD interview, but before results were known, thePage 2 of 9
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tion in STATA 6.0, assigned the patient to one of three
groups: results given to patient and doctor (40%), results
given only to patient (40%), or results given to neither
(20%). Patients in the first two groups were given a packet
with their PRIME-MD results, an explanation of these
results, a glossary of terms, and a cover letter encouraging
them to share their PRIME-MD results with the treating
ED physician. All patients, regardless of randomization
group, were provided a written invitation to speak with a
psychiatric social worker at the conclusion of their ED
visit All patients with PRIME-MD diagnoses "major
depression" or "r/o bipolar disorder" were assessed for
suicidality by the psychiatric social worker prior to
discharge.
The physicians caring for patients in the "tell both" group
were provided PRIME-MD results through identical pre-
printed Post-it™ notes affixed over the parts of the medical
record where the resident and the attending write their
notes. Each Post-it™ note indicated which PRIME-MD
domains were positive (or that the patient had no PRIME-
MD diagnoses) and referred the physician to additional
materials attached to the chart. These materials included a
one-page cover sheet that introduced the physician to
PRIME-MD, reviewed the evidence of its validity, and
listed the patient's PRIME-MD diagnoses. As part of the
study we produced a list of low-cost and no-cost psychiat-
ric care options that could be offered to patients as part of
their after care instructions. Unfortunately, many of the
agencies on the list have many-month-long waiting lists
for patients who do not have an acute psychiatric issue.
Apart from these interventions, there was no attempt to
alter usual care.
Methods of measurement
The primary outcome was whether each patient diagnosed
by the PRIME-MD software left the ED having had a psy-
chiatric consultation or with a referral for further evalua-
tion and treatment of their psychiatric condition. Any
indication that the patient was referred to a health care
provider for help with a mental health issue, including a
statement that the low-cost no-cost sheet had been pro-
vided was considered evidence of referral. Secondary out-
comes were: whether the ED physician made a psychiatric
diagnosis and whether the patient actually received fol-
low-up for the psychiatric condition. This information
was gleaned from standardized review of the medical
record and after care instructions, and follow-up patient
telephone interview which took place 2 to 4 weeks after
the visit. We questioned the treating resident just after the
patient had left the ED to ascertain whether she was aware
of the PRIME-MD results and how she had acted upon
them. Patient and physician interview procedures and
results can be found in the Appendix.
Data collection and processing
Two investigators independently reviewed the chief com-
plaints of all enrolled patients (presented independently
of all other data) and excluded patients who had been
inappropriately entered into the study. Trained research
associates abstracted the patient's demographics, chief
complaint, diagnoses, psychiatric consultations and psy-
chiatric referrals from the ED medical record to a stand-
ardized form. Interrater reliability was assessed on a 10%
sample of charts. Abstractor's were blinded to the patients'
randomization status and PRIME-MD results. STATA 8.0
was used for data verification, database management, and
statistical analysis. To maintain anonymity and confiden-
tiality, physician and patient identifiers were dropped
during database creation and replaced with randomly
assigned numbers.
Primary data analysis
We designed this study to estimate the treatment effect
with reasonable precision, not to perform formal hypoth-
esis tests [14]. We took a Bayesian approach to this trial
and incorporated data from our previous study and other
reasonable priors in the analysis [15]. We used beta distri-
butions to model all priors and likelihoods. For the con-
trol limb we set a prior distribution of beta (1.2, 15.8)
which has a mean of 7% and a 95% credible interval of
0% to 23%. This prior is based on the control limb or our
previous trial (7% (3 of 45) successes) but was widened to
account for potential differences between the trials. It's
information content is equivalent to a 17 person study.
For the two other limbs we used beta (0.3, 1.2) distribu-
tions which have a mean of 20% and 95% credible inter-
val of 0% to 87%. This wide interval reflected our
uncertainty regarding the effect of the intervention and
has information content equivalent to a study with a sam-
ple size of 1.5 subjects. All Bayesian calculations were per-
formed in FAST*PRO and STATA 8.0 [16].
Our determination of sample size was guided by Bayesian
estimations and traditional frequentist calculations. We
decided a priori that the intervention was only worth
doing if it resulted in more than 50% of subjects with a
PRIME-MD diagnosis being offered referral. Our reason-
ing was that given the myriad of competing demands in
the ED setting this particular intervention had to have a
substantial impact (not just an incremental improvement
over the status quo) in order to justify the cost and effort
expended. As mentioned above, the control group of our
previous trial had 3 of 45 patients with a PRIME-MD diag-
nosis receive psychiatric consultation or referral. A fre-
quentist two limb trial would require 21 patients per
group (80% power for difference between 50% and 7%,
alpha .05). We sought to behav 80 patients in each active
limb since we conservatively expected that at least 1/3rd of
enrolled subjects would have a PRIME-MD diagnosisPage 3 of 9
(page number not for citation purposes)
BMC Emergency Medicine 2005, 5:2 http://www.biomedcentral.com/1471-227X/5/2(42% did in our first study). Since the prior distribution
for the control limb was considerably narrower than for
the other limbs, we decided to randomize half that
number of patients to this limb so that the posterior dis-
tributions of all limbs would be of similar precision.[15].
To conserve resources, we planned an interim analysis
once we enrolled 40 patients in each active limb to deter-
mine whether the study had any chance of producing a
clinically important result. Data analysts were blinded to
the identity of the 3 experimental groups and the rand-
omization proportions.
Results
Focus groups
There was general uniformity of opinion on the following
themes: residents do not feel adequately trained to detect
and treat occult psychiatric illness, attending physicians
were concerned that focusing on psychiatric issues may
cause the housestaff (but not them) to overlook somatic
illness, and screening and diagnosis was pointless in a sys-
tem that lacked any viable means for providing follow-up
or treatment. No one questioned the validity of the
PRIME-MD. There was heterogeneity of opinion regarding
whether the ED was the proper place to screen and diag-
nose psychiatric conditions even if adequate follow-up
was available. Some ED residents and attendings candidly
revealed that they "did not go into emergency medicine to
make non-emergent psychiatric diagnoses."
Randomized trial
At the time of the interim analysis and the stopping of the
study, 4,054 patients had been triaged. 183 were eligible
and 127 were randomized (Figure 1). 14 patients left prior
to being seen, 4 did not complete their PRIME-MD ses-
sion, and 11 patients were excluded after randomization
when it was determined they had an unappreciated psy-
chiatric complaint (e.g. "I haven't slept in 3 nights"). 95
patients were included in the analysis: 32 in the tell-both
limb, 40 in the tell-patient limb and 23 in the tell-neither
control limb (Table 1). Frequent chief complaints were
musculoskeletal pain or minor trauma (23%), abdominal
pain +/- nausea +/- vomiting (23%), weak +/- dizzy
(12%), and headache (9%). No resident or attending saw
a disproportionate number of patients (Table 1).
The PRIME-MD session took between 4 and 8 minutes for
half the patients (range 2–35 minutes). PRIME-MD made
one or more diagnoses in 51 of the 95 (54%) patients
(Table 2). Mood and anxiety disorders predominated. 24
patients were diagnosed with major depression and 4
with r/o bipolar disorder. The psychiatric social worker
identified 2 patients in this group who were suicidal. The
physicians of both of these patients were informed and
appropriate assessment and treatment was instituted.
Interrater agreement for the chart abstraction exceeded
90% for all items. 16% of patients diagnosed by the
PRIME-MD were given a psychiatric consultation or refer-
ral in the ED (Table 3). While there was a suggestion that
the intervention increased the likelihood that patients
would be identified and offered treatment (control 11%,
tell-patient 15%, tell-both 18%), no group approached
the 50% level that we sought (Table 3 and Figure 2).
From the physician and patient questionnaires (response
rates 41% and 55% respectively, see Appendix for details)
we learned that: most physicians with a patient in the tell-
both group learned that patients' PRIME-MD status from
the stickers, not from the patient. Few patients said they
told their ED physician about the PRIME-MD results and
physicians confirmed that they were seldom told such
information. While physicians generally agreed with the
PRIME-MD diagnoses, they did not choose to act on
them, most commonly because "the visit wasn't about
that issue." Only 2 of 28 patients contacted at least 2
weeks after the ED visit reported seeing a physician or
mental health care professional about their psychiatric
problem.
Discussion
This small trial, when interpreted in the context of our
previous trial [4], is sufficient to make the following
points: 1) it is feasible to use the PRIME-MD in the ED, 2)
there is a high prevalence of psychiatric illness in the
ambulatory ED population, 3) in our ED, when physi-
cians or patients or both are informed of the presence of a
PRIME-MD psychiatric diagnosis, few psychiatric diag-
noses are made and few patients receive consultation or
referral to address the problem, 4) our strategy of using
the patient to initiate a discussion of the patient's mental
health did not work.
While 18% (95% Credible Interval 6%, 36%) of patients
in the tell-both group were given consultation or referral,
10% (95% Credible Interval -9%, 28%) more than in the
control group, we do not believe that the improvement
was of sufficient magnitude to justify using PRIME-MD in
the waiting room of our ED.
These findings are a bit disconcerting since the treatments
for many of these psychiatric conditions are highly effec-
tive and the morbidity of the conditions is considerable.
Furthermore, treatments for conditions related to the
patient's chief complaints (low back pain, general weak-
ness, etc.) have limited efficacy. It would therefore be
highly desirable to develop a method for identifying and
treating these patients' psychiatric conditions.
The focus groups and this trial suggest that emergency
physicians are reluctant to consider psychiatric illness inPage 4 of 9
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such as: discomfort with the content and length of the
psychiatric interview, lack of knowledge of diagnostic cri-
teria, lack of interest in the activity, and belief that the
activity is futile since the health care system provides few
resources for the non-psychotic, underinsured patients
who are the most likely target of this intervention. It might
be possible to have the computer refer patients directly to
providers, thereby bypassing the physicians' resistance,
but this could only occur in a system where viable referral
options exist. Until such time, it is unlikely that a success-
ful intervention can be developed until readily available
follow-up becomes available.
This study took place in a U.S. academic ED within a
health care system that provides extremely limited mental
health follow-up for underinsured and uninsured patients
who are not homicidal, suicidal or floridly psychotic, the
majority of patients in our study. Results might be differ-
ent in a system (such as the U.K.'s) that provides reasona-
ble treatment options for such patients. The inclusion
criteria are somewhat subjective. It is quite likely that eli-
gible patients were missed. Furthermore, it is possible that
PRIME-MD produced false positive and false negative
results. Nevertheless, it is highly unlikely that these selec-
tion and misclassification biases would affect our
conclusion. The small size of our study makes our esti-
mates imprecise, but not so much so that our conclusions
This graphic shows how the 95 subjects tallied in the final analysis were culled from the 4,054 patients seen in the ED during study hoursFigure 1
This graphic shows how the 95 subjects tallied in the final analysis were culled from the 4,054 patients seen in the ED during 
study hours. Patients were randomized to three groups: tell neither (PRIME-MD results not shared with the patient or physi-
cian – the control group), tell patient (PRIME-MD results shared with the patient), and tell both (PRIME-MD results shared 
with patient and physician). In the lowest level of boxes, the entry "ER MD Dx or Tx" indicates how many patients diagnosed 
by PRIME-MD were diagnosed, treated or referred by the emergency physician.
Adult patients presenting to ED
(N=4,054)
Ineligible
(N=3,871, 95%)
Deemed eligible
(N=183, 5%)
Did not finish
PRIME-MD
(N=4)
Randomization
(N=123)
Completed
PRIME-MD
(N=123)
Consented
(N=127, 69%)
Refused
(N=47, 26%)
Missed
(N=9, 5%)
Tell neither
(N=32)
Tell patient
(N=48)
Tell both
(N=40)
Not analyzed 2
o
randomization
status unknown
(N=3)
LWBS (N= 4)
Psychiatric complaint (N=5)
LWBS (N=5)
Psychiatric complaint (N=3)
LWBS (N=5)
Psychiatric complaint (N=3)
PRIME-
MD Dx
(N=9)
and
ED MD
Dx or Tx
(N=1)
No
PRIME-
MD Dx
(N=14)
PRIME-
MD Dx
(N=20)
and
ED MD
Dx or Tx
(N=3)
No
PRIME-
MD Dx
(N=20)
PRIME-
MD Dx
(N=22)
and
ED MD
Dx or Tx
(N=4)
No
PRIME-
MD Dx
(N=10)
Medically unstable (N = 467)
Straightforward complaint (N = 2574)
Psychiatric complaint (N=296)
Non-English speaking (N=167)
Other (N=267)
Legend
LWBS = Left without being seen
Dx = diagnosis
Tx = treatmentPage 5 of 9
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patient questionnaires seriously compromises their
utility.
We powered the study to look for large effects and cannot
comment on whether the use of PRIME-MD produces a
modest increase in psychiatric diagnosis and referral in
patients with occult psychiatric illness. In retrospect, we
might have listened to the focus group participants more
carefully. They candidly told us why they were not keen to
diagnose and treat these patients. We ignored this and
designed an intervention that attempted to use the
patients to force their hand. We might have had more suc-
cess had we organized a follow-up clinic for such patients
and directly addressed the physicians' attitudes. We also
learned that while the trained undergraduate student
research assistants did quite a good job identifying, con-
senting, and enrolling patients, they were less effective
with the physician questionnaire (40% completion rate).
We were unrealistic to expect that a junior person could
capture the attention of a busy ED resident to get the ques-
tionnaire completed. Finally, we might have used block
randomization to avoid the imbalance in assignments
that occurred in this study.
Conclusion
In summary, in our ED, telling PRIME-MD diagnoses to
the patient (and physician) did not substantially increase
the proportion of patients whose were diagnosed and
referred for treatment of their psychiatric condition in a
health care system that offered extremely limited follow-
up possibilities for such patients.
Table 1: Physician and patient information by study limb
Study Limb
Tell Neither Tell Patient Tell Both Total
Patient Characteristics
No. of patients 23 40 32 95
Age (y) mean (SD) 48(15) 46(14) 48(15) 47(15)
Female, No. (%) 12(53) 17(43) 19(60) 48(51)
Physician Characteristics
No. of Attendings 12 17 15 20
No. of Residents 19 30 30 51
No. of residents seeing:
1 patient 18 22 25 31
2 patients 1 4 3 9
3 patients 0 2 0 7
≥ 4 patients 0 0 0 4
Table 2: PRIME-MD diagnoses by study limb
Study Limb
Tell Neither Tell Patient Tell both Total
No. of patients 23 40 32 95
Patients with
Any PRIME-MD diagnostic domain (%) 9(39) 20(50) 22(69) 51(54)
1 PRIME-MD diagnostic domain 3(13) 8(20) 10(31) 21(22)
2 PRIME-MD diagnostic domains 2(9) 7(18) 5(16) 14(14)
3 PRIME-MD diagnostic domains 4(17) 1(3) 5(16) 10(11)
≥ 4 PRIME-MD diagnostic domains 0(0) 4(10) 2(6) 6(6)
Any mood diagnosis 7(30) 12(30) 17(53) 36(37)
Any anxiety diagnosis 4(17) 14(35) 10(31) 28(29)
Any OCD diagnosis 5(22) 6(15) 7(22) 18(19)
Any alcohol/dependence 1(4) 5(13) 6(19) 12(13)
Any phobia diagnosis 2(9) 5(13) 2(6) 9(9)
Any eating disorder 0(0) 0(0) 2(6) 2(2)Page 6 of 9
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Appendix
Methods
Physician questionnaire
Participating residents were approached as soon as each
patient was discharged from the ED, regardless of rand-
omization status. A research assistant administered one of
two versions of a structured questionnaire. Physicians
whose patient had a PRIME-MD diagnosis were asked
whether they knew the PRIME-MD diagnoses, how they
came to know them, whether they agreed with them (and
why), and whether they took any actions (and why). Phy-
sicians whose patient did not have a PRIME-MD diagnosis
were asked if they knew the patient's PRIME-MD status.
Patient questionnaire
The psychiatric social worker attempted to call each
patient during a 2 week interval beginning 2 weeks after
the ED visit. Each patient had been asked to provide a cur-
rent phone number at the time of behaviour. Patients
were asked 15 closed-ended questions about their current
physical and mental health in comparison to the day of
the ED visit, their knowledge of their PRIME-MD diag-
noses, whether they discussed PRIME-MD with their ED
physician, whether their ED physician addressed psychiat-
ric issues during their visit, whether they had been given a
referral regarding psychiatric issues, and what types of
health care they had received subsequent to the ED visit.
At the end of the interview, the social worker attempted to
help patients who desired intervention but had not
received it find an appropriate source of care.
Results
Physician questionnaire
19 of 44 (43%) physicians whose patient did not have a
PRIME-MD completed the short questionnaire. 3 of the 4
physicians in the tell-both group knew that the patient did
not have a PRIME-MD psychiatric diagnosis. In none of
the other 15 cases did the physician know the patient's
PRIME-MD status.
20 of 51 (39%) physicians who treated patients with a
PRIME-MD diagnosis completed the long-form question-
naire. In 10 of the 20 cases, the physician knew the
patient's PRIME-MD diagnosis, including 7 of 8 cases in
the tell-both group, 3 of 9 physicians in the tell-patient
group, and 0 of 3 patients in the tell-neither group. The
physician agreed with all of the PRIME-MD diagnoses in
5 of these cases, agreed with some in 4, and was unsure in
1.
6 of the 10 physicians unaware of the patient's PRIME-MD
diagnoses agreed with all (2) or some (4) of them when
informed of them. 1 disagreed, 2 had no opinion, and 1
did not answer. Only 2 of these 10 physicians wished that
Table 3: Psychiatric diagnosis, consultation and referral in patients with a PRIME-MD diagnosis, by study limb (N (%))
Study Limb
Tell Neither Tell Patient Tell Both
Patients with a PRIME-MD diagnosis and a: 9 20 22
Physician psychiatric diagnosis 0 (0%) 2 (10%) 4 (18%)
Physician psychiatric consultation or referral 1 (11%) 3 (15%) 4 (18%)
Physician psychiatric diagnosis, consultation, or referral 1 (11%) 3 (15%) 4 (18%)
Frequentist 95% CI 0%, 48% 3%, 38% 5%, 40%
Bayesian Analysis of these data* mean
95% Credible Interval
Prior distribution for limb 7%
0%, 23%
20%
0%, 87%
20%
0%, 87%
Likelihood for limb (from observed data) 11%
0%, 37%
15%
3%, 33%
18%
5%, 36%
Posterior distribution for limb 9%
1%, 22%
15%
4%,33%
18%
6%, 36%
*All probabilities are modelled as beta distributions. The traditional, frequentist 95% confidence intervals for the trial can be compared to the 95% 
credible intervals of the posterior distributions produced by the Bayesian analysis which combines prior beliefs about the results of each limb with 
the observed data (see text and [14]).Page 7 of 9
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ning the patient interview.
6 physicians stated that they informed the patient about a
psychiatric diagnosis (4) or wrote one in the medical
record (4). The physicians who did not cited reasons such
as "I was not confident of my diagnosis," "I did not want
to antagonize my patient," "I did not want to stigmatize
the patient," and "that was not what this visit was about."
2 physicians stated that they referred patients for further
evaluation and treatment of their psychiatric condition.
Those who did not cited "Did not believe patient would
benefit," "ED not the place for this activity," and "patient
did not meet DSM criteria for major depression," in addi-
tion to the aforementioned reasons.
Patient questionnaire
Despite confirming phone numbers at the time of behav-
iour, and making up to 10 attempts at contact, we reached
only 28 of the 51 patients with a PRIME-MD diagnosis.
Most patients reported that their physical health and men-
tal health were somewhat or greatly improved. 1 patient
reported that her physical health had worsened. 1 patient
reported that his mental health had deteriorated. Both of
PRIME-MD diagnosis versus whether the ED physician made a psychiatric diagnosis, consultation or referral, by study limbFigure 2
Title: PRIME-MD diagnosis versus whether the ED physician made a psychiatric diagnosis, consultation or referral, by study 
limb. For each study limb a 2 × 2 table depicts how each patient's PRIME-MD status (psychiatric diagnosis versus none) com-
pares to emergency physician's decision to make a psychiatric diagnosis, obtain psychiatric consultation, or refer the patient for 
evaluation of the psychiatric condition.
Tell Patient
PRIME-MD Diagnosis
Yes No
Yes 3 0 3Physician diagnosis, consultation, or
referral No 17 20 37
20 20 40
Tell Neither
PRIME-MD Diagnosis
Yes No
Yes 1 1 2Physician diagnosis, consultation, or
referral No 8 13 21
9 14 23
Tell Both
PRIME-MD Diagnosis
Yes No
Yes 4 3 7Physician diagnosis, consultation, or
referral No 18 7 25
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these patients had been provided with psychiatric referrals
but neither had received care.
14 of 21 patients who were told their PRIME-MD status in
the ED remembered it at the time of the call. Of these 14
patients, all but one correctly stated whether or not they
had PRIME-MD diagnoses, although they were somewhat
confused about which diagnoses they had, particularly
with regards to the presence of mood or anxiety disorders.
5 patients (none from the control group) reported dis-
cussing their PRIME-MD status with their ED physician. 2
reported seeing a mental health specialist subsequent to
the ED visit.
12 patients found the PRIME-MD evaluation "somewhat"
or "very" helpful, 2 found it "somewhat harmful" and 14
were neutral. 22 were glad that they took it. None of the 6
who were not glad had a PRIME-MD diagnosis. Patients
were generally grateful for the call and were generally not
that concerned that their mental health needs (as identi-
fied by PRIME-MD) had not been met.
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